Medical Condition News

RSS

Cross-disciplinary research experts develop Responsive Epilepsy Control System

The Brain Mind Welfare Team of National Cheng Kung University, Tainan, Taiwan, formed by cross-disciplinary research experts from information engineering, medical information and social science, has developed a Responsive Epilepsy Control System which proved to be successful in epileptic rats.

12 Jul 2010

Subtle mutation affecting epigenome may lead to inherited form of mental retardation: Researchers

A subtle mutation affecting the epigenome –- a set of dynamic factors that influence gene activity -- may lead to an inherited form of mental retardation that affects boys, find researchers at Children's Hospital Boston. The disorder, which also involves cleft lip or cleft palate, appears to hinge on an enzyme working in a biological pathway that may offer several potential drug targets.

12 Jul 2010

Exposure to traffic-related air pollutants associated with reduced HRV: Study

In patients with pre-existing heart or lung disease, being exposed to high levels of traffic-related air pollutants is associated with reduced heart rate variability —a risk factor for sudden cardiac death, reports a study in the July Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine.

12 Jul 2010

FDA accepts to review sNDA for SPRYCEL for treating adult patients with CML

Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced that the U.S. Food and Drug Administration has accepted for filing and review the supplemental New Drug Application for SPRYCEL (dasatinib) for the treatment of adult patients with newly diagnosed chronic myeloid leukemia in chronic phase.

12 Jul 2010

Researchers demonstrate that MSNs can effectively suppress tumors in mice

The application of nanotechnology in the field of drug delivery has attracted much attention in recent years. In cancer research, nanotechnology holds great promise for the development of targeted, localized delivery of anticancer drugs, in which only cancer cells are affected.

12 Jul 2010

New methods may help identify early signs of Alzheimer's disease: Study

Abnormal brain images combined with examination of the composition of the fluid that surrounds the spine may offer the earliest signs identifying healthy older adults at risk of developing Alzheimer's disease, well before cognitive problems emerge, a study by researchers at UC Davis has found.

12 Jul 2010

Sirtuin1 protein promotes memory, brain flexibility: MIT researchers

The same molecular mechanism that increases life span through calorie restriction may help boost memory and brainpower, researchers at MIT's Picower Institute for Learning and Memory report in the July 11 issue of Nature.

12 Jul 2010

Survival rates for people diagnosed with once-deadly cancer increase: Cancer Research UK

People diagnosed with breast, bowel and ovarian cancers and non-Hodgkin's lymphoma are today twice as likely to survive for at least 10 years as those diagnosed in the early 1970s according to new figures1 released by Cancer Research UK.

12 Jul 2010

Obama announces VA will ease rules for vets to qualify for stress disorder benefits

"President Barack Obama said Saturday the country has a 'solemn responsibility' to ensure that veterans with post-traumatic stress disorder get the help they need. Veterans Affairs Secretary Eric Shinseki is to announce new regulations Monday intended to make it easier for veterans with PTSD to receive government benefits. The new rules will not only apply to veterans of the Iraq and Afghanistan wars, but also those who served in previous conflicts. The regulations drop a provision requiring veterans to prove what caused their illness. Instead, veterans would have to show that the conditions surrounding the time and place of their service could have contributed to their illness" (Pace, 7/10).

12 Jul 2010

Alzheimer's Association recognizes four scientists for achievements in Alzheimer research at AAICAD 2010

The Alzheimer's Association recognized four scientists for their extraordinary achievements in advancing Alzheimer research at the Alzheimer's Association International Conference on Alzheimer's Disease 2010 in Honolulu, Hawaii.

12 Jul 2010

Fussy eating may be an “eating disorder” say researchers

Picky and fussy eaters are not just being difficult to please say U.S. researchers. They may be suffering from an eating disorder like anorexia or bulimia. Soon the disorder is to have an official name and the American Psychiatric Association plans to call them “selective eaters”.

11 Jul 2010

Diabetes reform plans do not please the AMA

In a bid to reform the way long term illnesses like diabetes are managed in Australia, the federal government announced a $436 million scheme to be introduced from 2012.

11 Jul 2010

Florbetaben PET tracer data to be presented at Alzheimer's Association ICAD 2010

Bayer HealthCare Pharmaceuticals, Inc. today announced that data on the company's investigational PET amyloid imaging tracer Florbetaben (BAY 94-9172) will be presented at the Alzheimer's Association International Conference on Alzheimer's Disease 2010 in Honolulu July 10 – 15.

9 Jul 2010

Lantheus signs new manufacturing, supply agreement with MDS Nordion for Mo-99

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced that it has signed a new manufacturing and supply agreement with MDS Nordion to purchase molybdenum-99 (Mo-99), the parent isotope of technetium-99m (Tc-99m). Mo-99 is used in Lantheus Medical Imaging's TechneLite® (Technetium Tc99m Generator) generators, which are sold throughout the world, and which produce Tc-99m, a medical isotope widely used in nuclear medicine imaging.

9 Jul 2010

MJFF awards $1.1M to six different projects for validating potential therapeutic targets for PD

The Michael J. Fox Foundation for Parkinson's Research today announced $1.1 million in total funding to six different projects aimed at validating potential therapeutic targets for Parkinson's disease.

9 Jul 2010

URI engineers develop new controlled drug delivery system using nanoparticles embedded in liposome

A new system for the controlled delivery of pharmaceutical drugs has been developed by a team of University of Rhode Island chemical engineers using nanoparticles embedded in a liposome that can be triggered by non-invasive electromagnetic fields.

9 Jul 2010

Namaste Charter School to use physical fitness and nutrition in childhood obesity prevention

At a time when the nation is focused on solving the problem of childhood obesity within a generation, and when school lunch revolutions are in full force - an inner city school in Chicago has found a winning formula. Namaste Charter School has a unique mission to use physical fitness and nutrition as avenues to reach higher student achievement, and this dedication to both academics and personal health has resulted in national recognition and a new, larger permanent home.

9 Jul 2010

EPO grants Brookhaven patent for use of vigabatrin in prevention of addiction to opioids

Catalyst Pharmaceutical Partners, Inc. today announced that the European Patent Office (EPO) granted to Brookhaven Science Associates/Brookhaven National Laboratory (Brookhaven) a European patent for the use of vigabatrin for the prevention of addiction to opioids (e.g., oxycodone, hydrocodone) used in pain management.

9 Jul 2010

Pfizer to present results of hemophilia studies at WFH 2010 Congress

Pfizer Inc, the world's leading biopharmaceutical company, today announced that the results of a number of hemophilia studies will be presented at the World Federation of Hemophilia 2010 Congress taking place July 10-14, 2010, in Buenos Aires, Argentina. Key research includes a pre-clinical evaluation of recombinant factor Xa as a potential new approach to restoring hemostasis, as well as a study assessing the potential for an engineered recombinant factor VIIa molecule to improve therapeutic outcomes in mouse models of hemophilia.

9 Jul 2010

Semuloparin reduces incidence of VTE in orthopedic surgery patients, study finds

An ultra-low-molecular-weight heparin called semuloparin has been found to reduce the incidence of venous thromboembolism in orthopedic surgery patients in a large clinical program being lead by a steering committee chaired by McMaster University professor Dr. Alexander Turpie.

9 Jul 2010

Medical Condition News

Cross-disciplinary research experts develop Responsive Epilepsy Control System

Subtle mutation affecting epigenome may lead to inherited form of mental retardation: Researchers

Exposure to traffic-related air pollutants associated with reduced HRV: Study

FDA accepts to review sNDA for SPRYCEL for treating adult patients with CML

Researchers demonstrate that MSNs can effectively suppress tumors in mice

New methods may help identify early signs of Alzheimer's disease: Study

Sirtuin1 protein promotes memory, brain flexibility: MIT researchers

Survival rates for people diagnosed with once-deadly cancer increase: Cancer Research UK

Obama announces VA will ease rules for vets to qualify for stress disorder benefits

Alzheimer's Association recognizes four scientists for achievements in Alzheimer research at AAICAD 2010

Fussy eating may be an “eating disorder” say researchers

Diabetes reform plans do not please the AMA

Florbetaben PET tracer data to be presented at Alzheimer's Association ICAD 2010

Lantheus signs new manufacturing, supply agreement with MDS Nordion for Mo-99

MJFF awards $1.1M to six different projects for validating potential therapeutic targets for PD

URI engineers develop new controlled drug delivery system using nanoparticles embedded in liposome

Namaste Charter School to use physical fitness and nutrition in childhood obesity prevention

EPO grants Brookhaven patent for use of vigabatrin in prevention of addiction to opioids

Pfizer to present results of hemophilia studies at WFH 2010 Congress

Semuloparin reduces incidence of VTE in orthopedic surgery patients, study finds

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News